CD99 and Ewing sarcoma: Recently, Çelik et al. described that the small molecule clofarabine was able to bind the extracellular portion of CD99, inhibiting the biological properties of Ewing sarcoma cells both in vitro and in vivo [106], thus suggesting a targeted use of an already developed drug.